InVitro International Q2 sales rise 5.3%, net income up 14.7% YoY, despite YTD sales down 11.6%.

InVitro International reported a 5.3% increase in sales for Q2 FY 2026, reaching $206,840, and a 14.7% rise in net income compared to the same quarter last year. However, year-to-date sales are down 11.6% compared to the first half of FY 2025, and net income for the first half of FY 2026 is 42.8% lower than the previous year. The CEO highlighted progress in the company's strategic direction and optimism about growing global acceptance of their non-animal testing technologies. InVitro aims to continue its streak of profitability while expanding its market reach amid changing regulatory policies.